Erlotinib (150 mg)

Erlotinib (150 mg)

Oxaliplatin 100 mg Injection contains Oxaliplatin (100 mg) and is an antineoplastic chemotherapy medicine used in the treatment of colorectal and other solid tumors by interfering with DNA replication in cancer cells.

- +

Form: Injection

Manufacturer: Generic Pharmaceuticals

Country of Origin: India

Overview: Oxaliplatin 100 mg Injection contains Oxaliplatin (100 mg) and is a prescription antineoplastic chemotherapy medicine used in the treatment of colorectal and other solid tumors by inhibiting DNA replication in cancer cells. Key Benefits: – Effective in treating colorectal cancer in combination regimens – Helps inhibit tumor cell DNA synthesis and growth – Administered under medical supervision Composition: Oxaliplatin (100 mg) How It Works: Oxaliplatin forms cross-links in DNA strands, which prevents cancer cell division and leads to cell death, particularly in rapidly dividing tumor cells. Usage Instructions: – Administer only by qualified healthcare professionals – Dosage and schedule determined by cancer type and patient condition – Not for self-administration Side Effects: – Nausea, vomiting, diarrhea – Peripheral neuropathy, cold sensitivity – Low blood cell counts increasing infection risk Precautions: – Regular monitoring of blood counts and neurologic function is required – Not recommended during pregnancy or breastfeeding unless advised by a physician – Inform your doctor of all current medications Storage Instructions: – Store below 25°C, protect from light, do not freeze Manufacturer: Generic Pharmaceuticals Disclaimer: To be sold by retail on the prescription of a registered medical practitioner only.

Composition

Oxaliplatin (100 mg)

Pack Size

1 Vial

Form

Injection

Manufacturer

Generic Pharmaceuticals

Brand

Oxaliplatin

Country of Origin

India

Strength

100 mg

Usage Category

Anticancer / Chemotherapy Medicines

Storage Conditions

do not freeze, protect from light, Store below 25°C

Prescription Required

Yes

Administration Route

Injection (Intravenous)

Dosage Form

Injection

Marketed By

Generic Pharmaceuticals

Reviews

There are no reviews yet.

Be the first to review “Erlotinib (150 mg)”

Your email address will not be published. Required fields are marked *

Requirement List
Scroll to Top